ABUSE OF DOMINANT POSITION: INQUIRY ORDERED AGAINST ROCHE

Published On: 01/05/2017

Practice Area: Competition Law

Authors:

Avimukt Dar
Shreya Suri
The Competition Commission of India (the "CCI"), in the matter of Biocon Limited ("Biocon"), Mylan Pharmaceuticals ("Mylan"), F. Hoffman La-Roche AG, Genetech Inc and Roche Products (India) Private Limited (collectively the "Roche Group") (the "CCI Order")[1] has held the Roche Group to be prima facie in contravention of section 4(2)(c) of the Competition Act, 2002 (the "Act").